Cholinesterase inhibitors

CL7 1.5 mg Pill - yellow capsule-shape

Pill with imprint CL7 1.5 mg is Yellow, Capsule-shape and has been identified as Rivastigmine Tartrate 1.5 mg. It is supplied by Macleods Pharmaceuticals Limited.

Rivastigmine is used in the treatment of Alzheimer's Disease; Parkinson's Disease and belongs to the drug class cholinesterase inhibitors. There is no proven risk in humans during pregnancy. Rivastigmine 1.5 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images

Rivastigmine transdermal (Rivastigmine transdermal [ riv-a-stig-meen ])-CL7 1.5 mg-1.5 mg-Yellow-Capsule-shape
Rivastigmine transdermal (Rivastigmine transdermal [ riv-a-stig-meen ])-CL7 1.5 mg-1.5 mg-Yellow-Capsule-shape

Rivastigmine transdermal
Generic Name: rivastigmine transdermal [ riv-a-stig-meen ]
Imprint: CL7 1.5 mg
Strength: 1.5 mg
Color: Yellow
Size: N/A
Shape: Capsule-shape
Availability: Prescription only
Drug Class: Cholinesterase inhibitors
Pregnancy Category: B - No proven risk in humans
CSA Schedule: Not a controlled drug
Labeler / Supplier: N/A
National Drug Code (NDC): 33342-0089
Inactive Ingredients: Magnesium stearate, Microcrystalline cellulose, Silicon dioxide, Gelatin, Titanium dioxide, Sodium lauryl sulfate, Ferric oxide red, Ferric oxide yellow, Hypromelloses,
Latest News
Related Drugs